📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Phase I study protocol for ex vivo lentiviral gene therapy for the inherited skin disease, Netherton syndrome. (2013)

First Author: Di WL
Attributed to:  BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/humc.2013.195

PubMed Identifier: 24329107

Publication URI: http://europepmc.org/abstract/MED/24329107

Type: Journal Article/Review

Volume: 24

Parent Publication: Human gene therapy. Clinical development

Issue: 4

ISSN: 2324-8637